Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sifavitor is an Italian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Founded in 1966 and headquartered in Milan, the company operates a significant manufacturing facility in Casaletto Lodigiano that is regularly inspected by the FDA and AIFA. Sifavitor provides a broad portfolio of small-molecule APIs and offers contract development and manufacturing (CDMO) services to global pharmaceutical clients. In 2007, the company was acquired by the INFA Group, which was subsequently acquired by Olon SpA in 2016, integrating Sifavitor into one of Europe's largest API manufacturing networks. The company's expertise spans various therapeutic areas, including cardiovascular, respiratory, and central nervous system disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sifavitor.